-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Neutral on Neurocrine Biosciences, Raises Price Target to $175

Benzinga·12/12/2025 14:17:59
Listen to the news
Mizuho analyst Uy Ear maintains Neurocrine Biosciences (NASDAQ:NBIX) with a Neutral and raises the price target from $146 to $175.